Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 19,283 | 18,992 | 69,798 | 76,321 | 17,291 |
| Cost of Goods | 1,132 | -27 | -789 | 1,295 | 2,266 |
| Gross Profit | 18,151 | 19,019 | 70,587 | 75,026 | 15,025 |
| Operating Expenses | 57,932 | 69,202 | 80,253 | 78,435 | 84,702 |
| Operating Income | -39,649 | -50,210 | -10,455 | -3,114 | -69,411 |
| Interest Expense | 10,309 | 10,291 | 7,357 | 11,356 | 8,801 |
| Other Income | -3,462 | 1,645 | 5,466 | -36,849 | 12,891 |
| Pre-tax Income | -53,420 | -58,856 | -12,346 | -51,319 | -65,321 |
| Income Tax | -4,498 | 518 | 3,055 | -711 | -947 |
| Net Income Continuous | -48,922 | -59,374 | -25,485 | -50,608 | -64,374 |
| Net Income | $-48,922 | $-59,374 | $-25,485 | $-50,608 | $-64,374 |
| EPS Basic Total Ops | -0.60 | -0.73 | -0.30 | -0.65 | -0.84 |
| EPS Basic Continuous Ops | -0.60 | -0.73 | -0.31 | -0.65 | -0.84 |
| EPS Diluted Total Ops | -0.60 | -0.73 | -0.30 | -0.65 | -0.84 |
| EPS Diluted Continuous Ops | -0.60 | -0.73 | -0.31 | -0.65 | -0.84 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.74 | -0.30 | N/A | N/A |
| EBITDA(a) | $-38,837 | $-49,487 | $-9,819 | $-2,542 | $-68,825 |